PULMONARY FIBROSIS FOUNDATION: Form 990, tax year 2019
View the entire original 990 at ProPublica ↗
- Organization
- PULMONARY FIBROSIS FOUNDATION (EIN 84-1558631)
- Tax period
- 2019-07-01 to 2020-06-30
- Filed
- 2021-04-15
- IRS object ID
- 202121059349301127
- Schema version
- 2019v5.1
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule G
- Schedule I
- Schedule J
- Schedule M
- Schedule O
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2021-04-15T10:08:30-05:00 | ReturnTs |
| Tax Period End | 2020-06-30 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | BDO USA LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 9500 Bryn Mawr Ave Suite 300 | AddressLine1Txt |
| City | Rosemont | CityNm |
| State Abbreviation | IL | StateAbbreviationCd |
| ZIP | 60018 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2019-07-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 841558631 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Pulmonary Fibrosis Foundation | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| In Care Of | % SCOTT STASZAK COO | InCareOfNm |
| Business Name Control | PULM | BusinessNameControlTxt |
| Phone | 3122652182 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 230 East Ohio Street Suite 500 | AddressLine1Txt |
| City | Chicago | CityNm |
| State Abbreviation | IL | StateAbbreviationCd |
| ZIP | 606113270 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | SCOTT STASZAK | PersonNm |
| Person Title | COO | PersonTitleTxt |
| Phone | 3125879272 | PhoneNum |
| Signature | 2021-04-13 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | Jacob Cook | PreparerPersonNm |
| PTIN | P01240455 | PTIN |
| Phone | 8476762000 | PhoneNum |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2019 | TaxYr |
| Build TS | 2022-09-23 18:48:47Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | SCOTT STASZAK | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 230 E Ohio Street Suite 500 | AddressLine1Txt |
| City | Chicago | CityNm |
| State Abbreviation | IL | StateAbbreviationCd |
| ZIP | 606113270 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $18,548,109 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | www.pulmonaryfibrosis.org | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 2000 | FormationYr |
| Legal Domicile State | CO | LegalDomicileStateCd |
| Activity Or Mission | To mobilize people and resources to provide access to high-quality care and lead research for a cure so that people with pulmonary fibrosis will live longer, healthier lives. | ActivityOrMissionDesc |
| Voting Members Governing Body | 11 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 11 | VotingMembersIndependentCnt |
| Total Employee | 40 | TotalEmployeeCnt |
| Total Volunteers | 1883 | TotalVolunteersCnt |
| Total Gross UBI | $2,000 | TotalGrossUBIAmt |
| PY Contributions Grants | $8,449,631 | PYContributionsGrantsAmt |
| CY Contributions Grants | $8,450,064 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $2,180,520 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $2,548,146 | CYProgramServiceRevenueAmt |
| PY Investment Income | $275,682 | PYInvestmentIncomeAmt |
| CY Investment Income | $293,084 | CYInvestmentIncomeAmt |
| PY Other Revenue | -$457,148 | PYOtherRevenueAmt |
| CY Other Revenue | -$589,250 | CYOtherRevenueAmt |
| PY Total Revenue | $10,448,685 | PYTotalRevenueAmt |
| CY Total Revenue | $10,702,044 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $293,007 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $342,863 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $3,585,863 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $3,557,722 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $1,076,890 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $4,609,314 | PYOtherExpensesAmt |
| CY Other Expenses | $7,391,038 | CYOtherExpensesAmt |
| PY Total Expenses | $8,488,184 | PYTotalExpensesAmt |
| CY Total Expenses | $11,291,623 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $1,960,501 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | -$589,579 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $10,914,467 | TotalAssetsBOYAmt |
| Total Assets EOY | $10,892,804 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $2,850,718 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $3,594,974 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $8,063,749 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $7,297,830 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | TO MOBILIZE PEOPLE AND RESOURCES TO PROVIDE ACCESS TO HIGH-QUALITY CARE AND LEAD RESEARCH FOR A CURE SO THAT PEOPLE WITH PULMONARY FIBROSIS WILL LIVE LONGER, HEALTHIER LIVES. | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | false | SignificantChangeInd |
| Expense | $2,540,164 | ExpenseAmt |
| Revenue | $172,700 | RevenueAmt |
| Desc | Outreach and Awareness: Total revenue recognized for the program was $2,423,701, which included contributions and sponsorships of $2,251,000 in addition to the program service revenue of $172,700. The PFF Ambassador Program empowers patients, caregivers, and health care professionals as spokespersons for the PF community on behalf of the PFF. PFF Ambassadors promote disease awareness, provide up-to-date information, and offer hope and inspiration to those affected by pulmonary fibrosis. PFF Ambassadors are available to speak at PFF Care Center Network events, support group meetings, fundraising events, (Continued on Schedule O) | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $2,137,834 | ExpenseAmt |
| Revenue | $1,944,397 | RevenueAmt |
| Desc | PFF Patient Registry: Total revenue recognized for the program was $2,098,260, which included contributions and sponsorships of $153,863 in addition to the program service revenue of $1,944,397. The PFF Registry (Registry) is a research effort that brings together multiple stakeholders including patients, health care providers, and researchers to advance research and improve the quality of life of patients with pulmonary fibrosis (PF). The crux of the Registry is comprised of an electronic database of patient information on diagnosis, treatment, and quality of life that is deidentified (made anonymous) and (Continued on Schedule O) | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $1,201,863 | ExpenseAmt |
| Revenue | $431,049 | RevenueAmt |
| Desc | PFF Summit: Total revenue recognized for the PFF Summit was $1,230,929, which included $636,508 in contributions and sponsorships received during the year or released from prior year receipts. PFF Summit 2019 is the PFF's biennial international health care conference on Pulmonary Fibrosis (PF). The goal of the PFF Summit is to foster a collaborative environment to improve education and awareness of PF and to identify new approaches to treat, and ultimately cure, this devastating disease. (Continued on Schedule O) | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Prog Srvc Expense | $3,171,740 | TotalOtherProgSrvcExpenseAmt |
| Total Other Prog Srvc Grant | $342,863 | TotalOtherProgSrvcGrantAmt |
| Total Program Service Expenses | $9,051,601 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (true) | LobbyingActivitiesInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | false | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | false | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (true) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | false | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | false | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (true) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (true) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (true) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | false | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | false | ForeignOfficeInd |
| Foreign Activities | false | ForeignActivitiesInd |
| More Than5000 K To Org | false | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | false | ProfessionalFundraisingInd |
| Fundraising Activities | Yes (true) | FundraisingActivitiesInd |
| Gaming Activities | false | GamingActivitiesInd |
| Operate Hospital | false | OperateHospitalInd |
| Grants To Organizations | Yes (true) | GrantsToOrganizationsInd |
| Grants To Individuals | false | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | false | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | false | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | false | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | false | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | Yes (true) | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | false | DisregardedEntityInd |
| Related Entity | false | RelatedEntityInd |
| Related Organization Ctrl Ent | false | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | false | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| IRP Document | 47 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (true) | BackupWthldComplianceInd |
| Employee | 40 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | Yes (true) | UnrelatedBusIncmOverLimitInd |
| Form990 T Filed | Yes (true) | Form990TFiledInd |
| Foreign Financial Account | false | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | Yes (true) | QuidProQuoContributionsInd |
| Quid Pro Quo Contri Discl | Yes (true) | QuidProQuoContriDisclInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | false | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | false | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 11 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 11 | IndependentVotingMemberCnt |
| Family Or Business Rln | false | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | false | MembersOrStockholdersInd |
| Election Of Board Members | false | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | false | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | false | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (true) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (true) | CompensationProcessOtherInd |
| Investment In Joint Venture | false | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | AL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | DC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | FL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | GA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ME | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ND | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | RI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | UT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WV | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | SCOTT STASZAK COO | PersonNm |
| Phone | 3122652182 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 230 EAST OHIO STREET SUITE 500 | AddressLine1Txt |
| City | CHICAGO | CityNm |
| State Abbreviation | IL | StateAbbreviationCd |
| ZIP | 60611 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (19 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Highest Compensated EmployeeHighestCompensatedEmployeeInd | Key EmployeeKeyEmployeeInd | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd |
|---|---|---|---|---|---|---|---|---|---|
| William T Schmidt | |||||||||
| Director/President and CEO | 40.0 | 0.0 | Yes (X) | $365,209 | $0 | $27,650 | |||
| Scott Staszak | |||||||||
| Chief Operating Officer | 40.0 | 0.0 | Yes (X) | $260,064 | $0 | $19,000 | |||
| Pauline Bianchi | |||||||||
| Senior VP, Research & Programs | 40.0 | 0.0 | $210,160 | $0 | $26,927 | Yes (X) | |||
| Laura Sadler | |||||||||
| Chief Marketing Officer | 40.0 | 0.0 | $172,997 | $0 | $9,619 | Yes (X) | |||
| Kerrie Trebonsky | |||||||||
| VP, Finance | 40.0 | 0.0 | $131,368 | $0 | $30,393 | Yes (X) | |||
| Rex Edwards | |||||||||
| VP, CCN & PFF Patient Registry | 40.0 | 0.0 | $144,586 | $0 | $16,225 | Yes (X) | |||
| Seth Klein | |||||||||
| Sr Director, Development Ops | 40.0 | 0.0 | $145,227 | $0 | $13,503 | Yes (X) | |||
| Zoe Bubany | |||||||||
| VP, Board & External Relations | 40.0 | 0.0 | $120,096 | $0 | $10,747 | Yes (X) | |||
| George Eliades | |||||||||
| Chairman | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | Yes (X) | ||
| Colleen Attwell | |||||||||
| Vice-Chair | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | Yes (X) | ||
| David McNinch | |||||||||
| Vice-Chair | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | Yes (X) | ||
| Laurie Chandler CFP | |||||||||
| Treasurer | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | Yes (X) | ||
| Terence Hales | |||||||||
| Secretary | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | Yes (X) | ||
| Mike Henderson | |||||||||
| Director | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| Jeff Harris | |||||||||
| Director | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| Wendi Mason | |||||||||
| Direcor | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| Andy Limper | |||||||||
| Director | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| Barbara Murphy | |||||||||
| Director | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| Dana A Ball | |||||||||
| Director | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $1,549,707 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $154,064 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 8 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | false | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp
Contractor Name ContractorName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | Dorothy Coyle Raclaw | PersonNm |
Contractor Address ContractorAddress
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 5855 N Kenneth Ave | AddressLine1Txt |
| City | CHICAGO | CityNm |
| State Abbreviation | IL | StateAbbreviationCd |
| ZIP | 60626 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Services | Marketing Consulting | ServicesDesc |
| Compensation | $144,575 | CompensationAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 1 | CntrctRcvdGreaterThan100KCnt |
| Fundraising | $1,115,387 | FundraisingAmt |
| All Other Contributions | $7,334,677 | AllOtherContributionsAmt |
| Noncash Contributions | $1,965,513 | NoncashContributionsAmt |
| Total Contributions | $8,450,064 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp (4 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt |
|---|---|---|---|
| PFF PATIENT REGISTRY | 900099 | $1,944,397 | $1,944,397 |
| PFF SUMMIT | 900099 | $431,049 | $431,049 |
| THERAPEUTICS NETWORK | 900099 | $125,225 | $125,225 |
| STRATEGIC PARTNERSHIPS | 900099 | $47,475 | $47,475 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $2,548,146 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $257,033 | TotalRevenueColumnAmt |
| Exclusion | $257,033 | ExclusionAmt |
Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $0 | RealAmt |
| Personal | $0 | PersonalAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $7,233,518 | SecuritiesAmt |
| Other | $1,962 | OtherAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $7,197,467 | SecuritiesAmt |
| Other | $1,962 | OtherAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $36,051 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $36,051 | TotalRevenueColumnAmt |
| Exclusion | $36,051 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $44,315 | FundraisingGrossIncomeAmt |
| Contri Rpt Fundraising Event | $1,115,387 | ContriRptFundraisingEventAmt |
| Fundraising Direct Expenses | $640,858 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$596,543 | TotalRevenueColumnAmt |
| Exclusion | -$596,543 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gaming Gross Income | $0 | GamingGrossIncomeAmt |
| Gaming Direct Expenses | $0 | GamingDirectExpensesAmt |
Net Income From Gaming NetIncomeFromGamingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Sales Of Inventory | $11,069 | GrossSalesOfInventoryAmt |
| Cost Of Goods Sold | $5,778 | CostOfGoodsSoldAmt |
Net Income Or Loss NetIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $5,291 | TotalRevenueColumnAmt |
| Exclusion | $5,291 | ExclusionAmt |
Other Revenue Misc OtherRevenueMiscGrp (2 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Unrelated Business RevenueUnrelatedBusinessRevenueAmt | ExclusionExclusionAmt |
|---|---|---|---|---|
| ADVERTISING | 900099 | $2,000 | $2,000 | |
| MISCELLANEOUS | 900099 | $2 | $2 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $2,002 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $10,702,044 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $2,548,146 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $2,000 | UnrelatedBusinessRevenueAmt |
| Exclusion | -$298,166 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part IX | Yes (X) | InfoInScheduleOPartIXInd |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $342,863 | TotalAmt |
| Program Services | $342,863 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Benefits To Members BenefitsToMembersGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $866,871 | TotalAmt |
| Program Services | $404,930 | ProgramServicesAmt |
| Management And General | $182,764 | ManagementAndGeneralAmt |
| Fundraising | $279,177 | FundraisingAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,296,402 | TotalAmt |
| Program Services | $1,396,434 | ProgramServicesAmt |
| Management And General | $471,917 | ManagementAndGeneralAmt |
| Fundraising | $428,051 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $28,680 | TotalAmt |
| Program Services | $17,175 | ProgramServicesAmt |
| Management And General | $8,709 | ManagementAndGeneralAmt |
| Fundraising | $2,796 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $161,009 | TotalAmt |
| Program Services | $80,274 | ProgramServicesAmt |
| Management And General | $48,948 | ManagementAndGeneralAmt |
| Fundraising | $31,787 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $204,760 | TotalAmt |
| Program Services | $104,143 | ProgramServicesAmt |
| Management And General | $56,745 | ManagementAndGeneralAmt |
| Fundraising | $43,872 | FundraisingAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $70,464 | TotalAmt |
| Management And General | $70,464 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $25,269 | TotalAmt |
| Management And General | $25,269 | ManagementAndGeneralAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $280,017 | TotalAmt |
| Program Services | $280,017 | ProgramServicesAmt |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,670,646 | TotalAmt |
| Program Services | $4,432,858 | ProgramServicesAmt |
| Management And General | $130,992 | ManagementAndGeneralAmt |
| Fundraising | $106,796 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $166,003 | TotalAmt |
| Program Services | $166,003 | ProgramServicesAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $243,802 | TotalAmt |
| Program Services | $177,583 | ProgramServicesAmt |
| Management And General | $19,986 | ManagementAndGeneralAmt |
| Fundraising | $46,233 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $12,938 | TotalAmt |
| Program Services | $7,016 | ProgramServicesAmt |
| Management And General | $3,031 | ManagementAndGeneralAmt |
| Fundraising | $2,891 | FundraisingAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $224,415 | TotalAmt |
| Program Services | $122,470 | ProgramServicesAmt |
| Management And General | $51,435 | ManagementAndGeneralAmt |
| Fundraising | $50,510 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $523,818 | TotalAmt |
| Program Services | $483,619 | ProgramServicesAmt |
| Management And General | $24,395 | ManagementAndGeneralAmt |
| Fundraising | $15,804 | FundraisingAmt |
Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $7,537 | TotalAmt |
| Program Services | $3,529 | ProgramServicesAmt |
| Management And General | $2,567 | ManagementAndGeneralAmt |
| Fundraising | $1,441 | FundraisingAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,036 | TotalAmt |
| Management And General | $2,036 | ManagementAndGeneralAmt |
Payments To Affiliates PaymentsToAffiliatesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $51,223 | TotalAmt |
| Program Services | $27,721 | ProgramServicesAmt |
| Management And General | $16,282 | ManagementAndGeneralAmt |
| Fundraising | $7,220 | FundraisingAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $44,813 | TotalAmt |
| Program Services | $24,411 | ProgramServicesAmt |
| Management And General | $10,348 | ManagementAndGeneralAmt |
| Fundraising | $10,054 | FundraisingAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| EVENT EXPENSES | $875,995 | $860,085 | $15,330 | $580 |
| DUES/SUBSCRIPTIONS/REGISTRAT | $33,694 | $21,982 | $11,272 | $440 |
| SOFTWARE EXPENSES | $335 | $0 | $335 | $0 |
| OTHER EXPENSES | $158,033 | $98,488 | $10,307 | $49,238 |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $11,291,623 | TotalAmt |
| Program Services | $9,051,601 | ProgramServicesAmt |
| Management And General | $1,163,132 | ManagementAndGeneralAmt |
| Fundraising | $1,076,890 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $221,577 | BOYAmt |
| EOY | $483,720 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,975,907 | BOYAmt |
| EOY | $4,670,786 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,166,592 | BOYAmt |
| EOY | $55,718 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $33,997 | EOYAmt |
Receivables From Officers Etc ReceivablesFromOfficersEtcGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $223,507 | BOYAmt |
| EOY | $137,343 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $223,703 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $180,713 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $69,870 | BOYAmt |
| EOY | $42,990 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,710,031 | BOYAmt |
| EOY | $4,863,723 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $99,963 | BOYAmt |
| EOY | $172,896 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $447,020 | BOYAmt |
| EOY | $431,631 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $10,914,467 | BOYAmt |
| EOY | $10,892,804 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,406,425 | BOYAmt |
| EOY | $1,523,757 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $104,311 | BOYAmt |
| EOY | $300,000 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,327,306 | BOYAmt |
| EOY | $1,207,629 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Escrow Account Liability EscrowAccountLiabilityGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $560,300 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $12,676 | BOYAmt |
| EOY | $3,288 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,850,718 | BOYAmt |
| EOY | $3,594,974 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,871,039 | BOYAmt |
| EOY | $4,012,393 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,192,710 | BOYAmt |
| EOY | $3,285,437 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $8,063,749 | BOYAmt |
| EOY | $7,297,830 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $10,914,467 | BOYAmt |
| EOY | $10,892,804 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | -$589,579 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | -$176,340 | NetUnrlzdGainsLossesInvstAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | false | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $5,558,537 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $5,775,504 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $5,989,047 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $8,449,631 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $8,450,064 | CurrentTaxYearAmt |
| Total | $34,222,783 | TotalAmt |
Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $5,558,537 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $5,775,504 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $5,989,047 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $8,449,631 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $8,450,064 | CurrentTaxYearAmt |
| Total | $34,222,783 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $14,561,195 | SubstantialContributorsTotAmt |
| Public Support Total170 | $19,661,588 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $14,534 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $11,635 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $69,969 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $273,967 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $257,033 | CurrentTaxYearAmt |
| Total | $627,138 | TotalAmt |
Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $2,101 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $1,060 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $691 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $234 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $2 | CurrentTaxYearAmt |
| Total | $4,088 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $34,854,009 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $11,720,813 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.56411 | PublicSupportCY170Pct |
| Public Support PY170 | 0.57970 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Form990 Schedule A Part VI Form990ScheduleAPartVIGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE A, PART II, SECTION A | FormAndLineReferenceDesc |
| Explanation | THE ORGANIZATION CHANGED THEIR ACCOUNTING YEAR END FROM DECEMBER 31(CALENDAR YEAR) TO JUNE 30 (FISCAL YEAR) IN 2015. IN ACCORDANCE WITH THE INSTRUCTIONS, THE COLUMNS FOR YEARS 2015-2019 CORRESPOND TO THE 5 PRIOR TAX RETURNS FILED: 2015 = 2015 RETURN (6/30/2016 YEAR-END) 2016 = 2016 RETURN (6/30/2017 YEAR-END) 2017 = 2017 RETURN (6/30/2018 YEAR-END) 2018 = 2018 RETURN (6/30/2019 YEAR-END) 2019 = 2019 RETURN (6/30/2020 YEAR-END) | ExplanationTxt |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
Total Grassroots Lobbying TotalGrassrootsLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $40,551 | FilingOrganizationsTotalAmt |
Total Direct Lobbying TotalDirectLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $239,466 | FilingOrganizationsTotalAmt |
Total Lobbying Expend TotalLobbyingExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $280,017 | FilingOrganizationsTotalAmt |
Other Exempt Purpose Expend OtherExemptPurposeExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $8,771,584 | FilingOrganizationsTotalAmt |
Total Exempt Purpose Expend TotalExemptPurposeExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $9,051,601 | FilingOrganizationsTotalAmt |
Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $602,580 | FilingOrganizationsTotalAmt |
Grassroots Nontaxable GrassrootsNontaxableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $150,645 | FilingOrganizationsTotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tot Lbbyng Grassroot Mns Non Tx | TotLbbyngGrassrootMnsNonTxGrp | |
| Tot Lbby Expend Mns Lbbyng Non Tx | TotLbbyExpendMnsLbbyngNonTxGrp |
Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $507,873 | CurrentYearMinus3Amt |
| Current Year Minus2 | $456,061 | CurrentYearMinus2Amt |
| Current Year Minus1 | $466,993 | CurrentYearMinus1Amt |
| Current Year | $602,580 | CurrentYearAmt |
| Total | $2,033,507 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Lobbying Ceiling | $3,050,261 | LobbyingCeilingAmt |
Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $43,156 | CurrentYearMinus3Amt |
| Current Year Minus2 | $21,008 | CurrentYearMinus2Amt |
| Current Year Minus1 | $79,435 | CurrentYearMinus1Amt |
| Current Year | $280,017 | CurrentYearAmt |
| Total | $423,616 | TotalAmt |
Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $126,968 | CurrentYearMinus3Amt |
| Current Year Minus2 | $114,015 | CurrentYearMinus2Amt |
| Current Year Minus1 | $116,748 | CurrentYearMinus1Amt |
| Current Year | $150,645 | CurrentYearAmt |
| Total | $508,376 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grassroots Ceiling | $762,564 | GrassrootsCeilingAmt |
Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $120 | CurrentYearMinus3Amt |
| Current Year Minus1 | $58,081 | CurrentYearMinus1Amt |
| Current Year | $40,551 | CurrentYearAmt |
| Total | $98,752 | TotalAmt |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Art Public Exhibition Amounts | ArtPublicExhibitionAmountsGrp | |
| Held Works Art | HeldWorksArtGrp | |
| CY Minus3 Yr Endwmt Fund | CYMinus3YrEndwmtFundGrp | |
| CY Minus4 Yr Endwmt Fund | CYMinus4YrEndwmtFundGrp | |
| Land | LandGrp | |
| Buildings | BuildingsGrp | |
| Leasehold Improvements | LeaseholdImprovementsGrp |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $154,338 | OtherCostOrOtherBasisAmt |
| Depreciation | $118,513 | DepreciationAmt |
| Book Value | $35,825 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $69,365 | OtherCostOrOtherBasisAmt |
| Depreciation | $62,200 | DepreciationAmt |
| Book Value | $7,165 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $42,990 | TotalBookValueLandBuildingsAmt |
| Federal Income Tax Liability | $0 | FederalIncomeTaxLiabilityAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | CAPITAL LEASE OBGLIGATION | Desc |
| Amt | $3,288 | Amt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $3,288 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $11,172,340 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | -$176,340 | NetUnrealizedGainsInvstAmt |
| Revenue Not Reported | -$176,340 | RevenueNotReportedAmt |
| Revenue Subtotal | $11,348,680 | RevenueSubtotalAmt |
| Other Revenues Not Included | -$646,636 | OtherRevenuesNotIncludedAmt |
| Revenue Not Reported Fincl Stmt | -$646,636 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $10,702,044 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $11,938,259 | TotExpnsEtcAuditedFinclStmtAmt |
| Other Expenses Included | $646,636 | OtherExpensesIncludedAmt |
| Expenses Not Reported | $646,636 | ExpensesNotReportedAmt |
| Expenses Subtotal | $11,291,623 | ExpensesSubtotalAmt |
| Total Expenses Per Form990 | $11,291,623 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| SCHEDULE D, PART X, LINE 2: | The Organization is exempt from income taxes under Section 501(c)(3) of the Internal Revenue Code ("IRC"), except for net income derived from unrelated business activities. In addition, the Organization qualifies for the charitable contribution deduction under Section 170(b)(1)(A) and has been classified as an organization other than a private foundation under IRC Section 509(a). The Organization's income tax filings are subject to audit by various taxing authorities. In evaluating the Organization's activities, management believes its position of tax-exempt status is based on current facts and circumstances and there have been no uncertain positions taken related to recording income taxes. It is the policy of the Organization to include in management and general expenses penalties and interest assessed by income taxing authorities. There were no penalties from taxing authorities included in management and general expenses for the year ended June 30, 2020. |
| Schedule D, Part XI, Line 4b - Other Adjustments | Special Events: $(640,858) Sale of Goods: (5,778) Total: $(646,636) |
| Schedule D, Part XII, Line 2d - Other Adjustments | Special Events: $640,858 Sale of Goods: 5,778 Total: $646,636 |
Schedule G IRS990ScheduleG
Fundraising Event Information FundraisingEventInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Event1 | PFF Walks | Event1Nm |
| Gross Receipts Event1 | $767,510 | GrossReceiptsEvent1Amt |
| Charitable Contri Event1 | $767,510 | CharitableContriEvent1Amt |
| Rent Facility Costs Event1 | $1,500 | RentFacilityCostsEvent1Amt |
| Food And Beverage Event1 | $2,053 | FoodAndBeverageEvent1Amt |
| Entertainment Event1 | $4,195 | EntertainmentEvent1Amt |
| Other Direct Expenses Event1 | $393,646 | OtherDirectExpensesEvent1Amt |
| Event2 | Broadway Belts | Event2Nm |
| Gross Receipts Event2 | $392,192 | GrossReceiptsEvent2Amt |
| Charitable Contri Event2 | $347,877 | CharitableContriEvent2Amt |
| Gross Revenue Event2 | $44,315 | GrossRevenueEvent2Amt |
| Food And Beverage Event2 | $67,228 | FoodAndBeverageEvent2Amt |
| Entertainment Event2 | $483 | EntertainmentEvent2Amt |
| Other Direct Expenses Event2 | $171,753 | OtherDirectExpensesEvent2Amt |
| Other Events Total | 0 | OtherEventsTotalCnt |
| Gross Receipts Total | $1,159,702 | GrossReceiptsTotalAmt |
| Charitable Contributions Tot | $1,115,387 | CharitableContributionsTotAmt |
| Gross Revenue Total Events | $44,315 | GrossRevenueTotalEventsAmt |
| Rent Fclty Costs Total Events | $1,500 | RentFcltyCostsTotalEventsAmt |
| Food And Beverage Total Events | $69,281 | FoodAndBeverageTotalEventsAmt |
| Entertainment Total Events | $4,678 | EntertainmentTotalEventsAmt |
| Oth Direct Expnss Total Events | $565,399 | OthDirectExpnssTotalEventsAmt |
| Direct Expense Summary Events | $640,858 | DirectExpenseSummaryEventsAmt |
| Net Income Summary | -$596,543 | NetIncomeSummaryAmt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (6 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt | Address Line2USAddress/AddressLine2Txt |
|---|---|---|---|---|---|---|---|---|
| Weill Medical College of Cornell University | ||||||||
| 1300 York Ave | New York | NY | 10065 | 131623978 | 501(c)(3) | $50,000 | See Part IV | |
| Trustees of the University of Pennsylvania | ||||||||
| 3451 Walnut St | Philadelphia | PA | 19104 | 231352685 | 501(c)(3) | $50,000 | See Part IV | Franklin Bldg P-221 Mailstop 6205 |
| Weill Medical College of Cornell University | ||||||||
| 1300 York Ave | New York | NY | 10065 | 131623978 | 501(c)(3) | $50,000 | See Part IV | |
| Mayo Clinic | ||||||||
| 200 First St NW | Rochester | MN | 55905 | 416011702 | 501(c)(3) | $50,000 | See Part IV | |
| The Rector & Visitors of the Univ of VA | ||||||||
| PO Box 400202 | Charlottesville | VA | 22904 | 546001796 | 501(c)(3) | $50,000 | See Part IV | |
| UCSF | ||||||||
| 1855 Folsom St | San Francisco | CA | 94143 | 946036493 | 501(c)(3) | $50,000 | See Part IV | MCB 425 Box 0897 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 6 | Total501c3OrgCnt |
Supplemental Information Detail SupplementalInformationDetail (7 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Schedule I, Part I, Line 2 | For larger grants, the Organization requests semi-annual reports detailing the use of grant funds from the recipient organizations. |
| Schedule I, Part II, Line 1(h) Purpose of Grant | (1) SINGLE CELL RNA-SEQUENCING BASED CHARACTERIZATION OF BRONCHOALVEOLAR CELL POPULATIONS IN HYPERSENSITIVITY PNEUMONITIS Hypersensitivity pneumonitis (HP) can be difficult to diagnose and may be confused with other fibrotic lung conditions including idiopathic pulmonary fibrosis. This project will use a novel technology that measures gene expression in individual lung immune cells, obtained by performing a washing of the lung, to investigate the origin, nature and activation states of these cells. Additionally, the gene expression data will be used to identify a unique HP 'molecular signature' which can be used to differentiate the condition from other types of fibrotic lung disease. |
| Schedule I, Part II, Line 2(h) Purpose of Grant | (2) PULMONARY FIBROSIS AS A DISEASE OF DISRUPTED EPITHELIAL PROTEOSTASIS AND CELL STRESS Mutations in the Surfactant Protein C (SFTPC) gene have been identified in a subset of patients with familial pulmonary fibrosis. These mutations result in misfolded proteins that activate epithelial cell stress pathways, providing an opportunity to study the pathway from cell stress to lung fibrosis. Using a recently published murine SFTPC mutant lung fibrosis model and primary human IPF cells from explanted lungs, the grant will address the central hypothesis that epithelial cell stress drives lung fibrosis by altering cell repair mechanisms. This work will provide mechanistic insight into IPF pathogenesis with the overall goal of identifying targetable upstream pathways. |
| Schedule I, Part II, Line 3(h) Purpose of Grant | (3) THE DEVELOPMENT AND VALIDATION OF A DISEASE SPECIFIC HEALTH RELATED QUALITY OF LIFE INSTRUMENT FOR PATIENTS WITH CHRONIC HYPERSENSITIVITY PNEUMONITIS (CHP) Patients with CHP have variable clinical courses and the tests currently used to measure disease status, such as pulmonary function testing, are not the outcomes that are truly important to patients. As more CHP patients are enrolled in therapeutic trials, this grant proposes to develop a patient-centered outcome specific to CHP patients that comprehensively covers the aspects of quality of life that patients have identified as important in prior research. The proposed survey will offer a patient-centered perspective on disease severity and treatment effectiveness. |
| Schedule I, Part II, Line 4(h) Purpose of Grant | (4) Targeting the HIPPO/YAP Pathway through G Protein-Coupled Receptors: A Viable Mechanism to Treat Pulmonary Fibrosis At the cellular level, one of the core contributors to pulmonary fibrosis are activated mesenchymal cells referred to as myofibroblasts. Recent studies have identified an important role for YAP and TAZ transcription factors in activating myofibroblasts in tissue fibrosis. It has recently been reported that G-protein coupled receptor (GPCR) activation can block nuclear localization and activity of YAP/TAZ. The grant hypothesizes that selectively activating these receptors in lung myofibroblasts will ablate the profibrotic effect of these cells in idiopathic pulmonary fibrosis (IPF). In support of this concept the grant will present preliminary data testing a small panel of GPCR ligands in lung fibroblasts and epithelial cells. The successful history of GPCR ligands as therapeutics has led to a highly translational approach to pursue this hypothesis. |
| Schedule I, Part II, Line 5(h) Purpose of Grant | (5) ROLE OF POLYUNSATURATED FATTY ACIDS IN PULMONARY FIBROSIS There is a desperate need for new treatments as modifiable risk factors may be targets for therapy that improve outcomes for patients. Using the Pulmonary Fibrosis Foundation Registry and Biorepository, this grant will to examine whether higher omega-3 intake is associated with better lung function and exercise capacity in adults with pulmonary fibrosis. It will examine mechanisms that may be driving these associations including whether omega-3 fatty acids slow accelerated aging which is a key characteristic of pulmonary fibrosis. |
| Schedule I, Part II, Line 6(h) Purpose of Grant | (6) CLOSING THE EVIDENCE GAP IN ILD: THE USE OF REAL WORLD OBSERVATIONAL COHORTS TO UNDERSTAND THE NATURAL HISTORY OF FIBROTIC LUNG This grant will develop a model for integrating clinical research into routine clinical care in order to generate evidence that is applicable to diverse, real-world patient populations and aligned with the clinical questions that are priorities for patients, caregivers and providers. The grant proposes to harness the robust patient-level and health system level information continuously generated and captured in the electronic health record, to study the association between predictors and outcomes, which can be used to develop best practices in ILD care. |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Housing Allowance Or Residence | Yes (X) | HousingAllowanceOrResidenceInd |
| Written Policy Ref T And E Expnss | false | WrittenPolicyRefTAndEExpnssInd |
| Substantiation Required | false | SubstantiationRequiredInd |
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Written Employment Contract | Yes (X) | WrittenEmploymentContractInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | false | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | false | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | false | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (7 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| William T Schmidt | ||||||||||||||
| Director/President and CEO | $365,209 | $0 | $0 | $0 | $0 | $0 | $25,000 | $0 | $2,650 | $0 | $392,859 | $0 | $0 | $0 |
| Scott Staszak | ||||||||||||||
| Chief Operating Officer | $260,064 | $0 | $0 | $0 | $0 | $0 | $19,000 | $0 | $0 | $0 | $279,064 | $0 | $0 | $0 |
| Laura Sadler | ||||||||||||||
| Chief Marketing Officer | $172,997 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $9,619 | $0 | $182,616 | $0 | $0 | $0 |
| Pauline Bianchi | ||||||||||||||
| Senior VP, Research & Programs | $210,160 | $0 | $0 | $0 | $0 | $0 | $25,000 | $0 | $1,927 | $0 | $237,087 | $0 | $0 | $0 |
| Kerrie Trebonsky | ||||||||||||||
| VP, Finance | $131,368 | $0 | $0 | $0 | $0 | $0 | $9,157 | $0 | $21,236 | $0 | $161,761 | $0 | $0 | $0 |
| Rex Edwards | ||||||||||||||
| VP, CCN & PFF Patient Registry | $144,586 | $0 | $0 | $0 | $0 | $0 | $12,532 | $0 | $3,693 | $0 | $160,811 | $0 | $0 | $0 |
| Seth Klein | ||||||||||||||
| Sr Director, Development Ops | $145,227 | $0 | $0 | $0 | $0 | $0 | $7,630 | $0 | $5,873 | $0 | $158,730 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Schedule J, Part I, Line 1a | CEO RESIDES IN MD AND CANNOT RELOCATE AT THIS TIME, HOWEVER, HE NEEDS TO SPEND SUBSTANTIAL TIME IN CHICAGO AND THEREFORE PFF AGREED TO PROVIDE A HOUSING ALLOWANCE. |
| Schedule J, Part I, Line 1b | DETAILS ARE DISCLOSED IN CEO'S EMPLOYMENT CONTRACT. WE DO NOT OFFER THIS ARRANGEMENT TO OTHER STAFF MEMBERS AND THUS DO NOT HAVE A WRITTEN POLICY FOR A HOUSING ALLOWANCE. |
Schedule M IRS990ScheduleM
| Field | Value | IRS element (for citing) |
|---|---|---|
| Works Of Art | WorksOfArtGrp | |
| Art Historical Treasures | ArtHistoricalTreasuresGrp | |
| Art Fractional Interest | ArtFractionalInterestGrp | |
| Books And Publications | BooksAndPublicationsGrp | |
| Clothing And Household Goods | ClothingAndHouseholdGoodsGrp | |
| Cars And Other Vehicles | CarsAndOtherVehiclesGrp | |
| Boats And Planes | BoatsAndPlanesGrp | |
| Intellectual Property | IntellectualPropertyGrp |
Securities Publicly Traded SecuritiesPubliclyTradedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 6 | ContributionCnt |
| Noncash Contributions Rpt F990 | $1,965,178 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | FMV | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities Closely Held Stock | SecuritiesCloselyHeldStockGrp | |
| Secur Prtnrshp Trust Intrsts | SecurPrtnrshpTrustIntrstsGrp | |
| Securities Miscellaneous | SecuritiesMiscellaneousGrp | |
| Qualified Contrib Hist Struct | QualifiedContribHistStructGrp | |
| Qualified Contrib Other | QualifiedContribOtherGrp | |
| Real Estate Residential | RealEstateResidentialGrp | |
| Real Estate Commercial | RealEstateCommercialGrp | |
| Real Estate Other | RealEstateOtherGrp | |
| Collectibles | CollectiblesGrp | |
| Food Inventory | FoodInventoryGrp | |
| Drugs And Medical Supplies | DrugsAndMedicalSuppliesGrp | |
| Taxidermy | TaxidermyGrp | |
| Historical Artifacts | HistoricalArtifactsGrp | |
| Scientific Specimens | ScientificSpecimensGrp | |
| Archaeological Artifacts | ArchaeologicalArtifactsGrp |
Other Non Cash Contri Table OtherNonCashContriTableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Desc | Other | Desc |
| Contribution | 1 | ContributionCnt |
| Noncash Contributions Rpt F990 | $335 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | FMV | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Any Property That Must Be Held | false | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | Yes (true) | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | false | ThirdPartiesUsedInd |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (30 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| CONTINUED FROM FORM 990, PART III, LINE 4A: | and other disease awareness and education programs. During the fiscal year, the PFF accepted 14 new PFF Ambassadors into the programs. These Ambassadors consist of pulmonary fibrosis patients, caregivers, lung transplant recipients, and those who lost a loved one to the disease. PFF Ambassadors spoke at 34 in-person events including Support Group meetings, educational conferences and fundraisers and had over a dozen virtual opportunities as society shifted during COVID-19. The PFF Daughters Program was founded to expand awareness of pulmonary fibrosis, especially among policymakers, via grassroots events and fundraisers across the nation, in order to generate a broader understanding of the impact the disease has on those living with PF and their families. The PFF Daughters program is now the PFF Advocates, with more than 1,000 members. Pulmonary Fibrosis Awareness Month (September) is when the PF community unites as a collective voice to enhance disease awareness and provide outreach to those in need. During Pulmonary Fibrosis Awareness Month, the PF community joined the PFF and participated in the #BlueUp4PF campaign, attended educational events, hosted Team PFF fundraising events, participated in webinars and spread disease awareness through social media. More Than A Cough Campaign: In September 2019, the Pulmonary Fibrosis Foundation (PFF) and Three Lakes Foundation (TLF) joined forces to launch a new partnership to combat PF. The "More Than A Cough" (MTAC) campaign was created to drive public awareness of pulmonary fibrosis (PF) and was a key piece of this effort. The innovative multi-channel MTAC campaign, which ran through April 2020, featured two animated characters, Norm and Jennifer, designed to illustrate the experiences of patients and caregivers. They were introduced via digital, social media, broadcast, and print advertisements in Chicago followed by a Google campaign in the test markets of Birmingham, Scottsdale, and Nashville. MTAC produced over 62 million impressions, 432,000 visitors to the MTAC landing page, and 53,000 downloads of the pulmonary fibrosis risk list. The campaign achieved a 576% increase in the search term "pulmonary fibrosis" in Chicago alone. |
| CONTINUED FROM FORM 990, PART III, LINE 4B: | independently managed by a data coordinating center. The Registry also collects biological specimens that patients have agreed to give, which are deidentified and independently managed by a medical specimen storage facility associated with the data coordinating center. The Registrys key aims are to: (1) conduct benchmarking and quality improvement efforts across the PFFs medical center network; (2) develop a more representative understanding of PF patient in the United States; (3) facilitate research in identified priority areas; and (4) increase the PFFs reach within the PF community. As of June 30, 2020, the Registry has activated 42 sites and identified 2,003 patients for enrollment. This vital program is completing its first phase and will embark on the next phase to continue to capture clinical patient information and expand into the community to collect information from other patients, lung transplant recipients, caregivers, and families. This will provide a more representative understanding of the PF community and create a robust pool of engaged community members for advocacy, clinical trials, and other research. To learn more about the PFF Patient Registry, please go to: http://bit.ly/pffregistry. |
| CONTINUED FROM FORM 990, PART III, LINE 4C: | The PFF Summit features an innovative continuing medical education (CME) program for Health Care Professionals and sessions for PF patients and caregivers that address their growing educational needs. (Note: Some expenses for the PFF Summit 2019 were included in the 2018 Form 990). |
| FORM 990, PART III, LINE 4D: | 1. Marketing: Activities were first concentrated during September, October, and November to leverage exposure offered by Pulmonary Fibrosis Awareness Month (September) and through the PFF Summit (November). In January, we commissioned a first of its kind national survey to measure public awareness of PF. The online survey was administered to 2,103 adults nationwide and we found that 86% of Americans do not know the symptoms of PF. The survey announcement was followed by a satellite media tour with TV and radio stations across the U.S. to drive awareness of PF. On Feb. 27, Dr. Cosgrove conducted 20 interviews with television and radio stations across the country. Using Rare Disease Awareness Week as a story driver, he described the symptoms and risk factors of PF and encouraged the audience to visit AboutPF.org or discuss the disease with their physician. We also recorded and distributed an audio news release to radio stations nationwide. These activities overall continued to increase awareness of PF and its risk factors nationwide, generating more than 515.1 million impressions and successfully grew traffic to the AboutPF.org microsite and to the PFF's website, pulmonaryfibroisis.org. Inquiries to the PFF's Patient Communication Center (PCC) also grew as a result of the campaign. Constituencies served by the marketing campaign extension in traditional and digital media included patients and potential patients; caregivers and families; healthcare providers; at-risk populations. 2. Education: The Pulmonary Fibrosis Foundation (PFF) is committed to providing quality disease education to the pulmonary fibrosis community. The PFF strives to provide patients, caregivers, family members, and health care providers with the resources necessary to more fully understand PF, and to provide patients with the tools necessary to live with the disease and improve their quality of life. The Foundation created a variety of new materials and resources for the PF community in fiscal year 2019-2020. Printed materials included the PF Family and Friends Postcards. The PFF Oxygen Basics Booklet was translated to Spanish. The following materials were updated to include new PFF resources and reflect new treatment information due to medication label expansions: Pulmonary Fibrosis Information Guide (and translations), ILD Nursing and Allied Health Guide, Nintedanib Fact Sheet, Pirfenidone Fact Sheet, Scleroderma-Associated ILD Fact Sheet, PF Clinical Trial Postcard, and About PFF Brochure. Printed educational materials are distributed through the PFF Patient Communication Center and at education events and conferences. The PFF developed guidance and FAQ documents about COVID-19 and curated a list of relevant resources related to COVID-19 to provide reliable information about the pandemic to members of the PF community. The PFF also produced two videos about COVID-19 titled "PFF COVID-19 Guidance"COVID-19 Everyday Precautions." The PFF added a new patient story video to the Life with Pulmonary Fibrosis series in English and Spanish. Additionally, the PFF produced a new series of short videos titled "Words of Wisdom" which provides perspectives and advice from caregivers in the PF community. These videos can be found on the Foundation's YouTube channel. The PFF Disease Education Webinar Series engages the PF community in an online webinar discussion where they learn from, connect with, and pose questions to leading pulmonary fibrosis specialists each month. Ten webinars were presented in fiscal year 2019-20 and all can be viewed on the PFF website at https://bit.ly/pffwebinars and on the Foundation's YouTube channel. Topics addressed during this time period include idiopathic interstitial lung diseases, supplemental oxygen, treatment options, PF research, occupational PF, and COVID-19. |
| 3. PFF Care Center Network | The Pulmonary Fibrosis Foundation (PFF) is dedicated to promoting earlier recognition and diagnosis of pulmonary fibrosis and ensuring that patients receive the highest quality healthcare. As part of that commitment, over the past three years the PFF has worked with the PF medical community to establish the PFF Care Center Network (CCN), where people with PF can find experienced medical professionals who understand their disease and support services to improve the quality of their lives. The goals of the PFF CCN is to deliver state of the art, patient-centered care; to disseminate education to support our patients, caregivers and providers; to give voice to the needs of our community through advocacy and fundraising; and to accelerate research in PF both directly and through collaborations and networking. The CCNs programmatic service accomplishments are highlighted below. The PFF Medical team has developed a new PFF CCN Annual Report to all 68 care centers. This center based report will have a strong emphasis on benchmarking, research, clinical care, community-based clinical support, and patient satisfaction. We anticipate that with this data centric approach we will be better positioned to understand the unique characteristics within our network. The Palliative Care Services in Care Centers Survey working group strived for 100% Care Center participation with an estimated 136 survey responses. The aim of this survey is to understand the role of palliative care services, perspectives and current resources available to providers who care for patients with pulmonary fibrosis and interstitial lung disease. The survey was disseminated to physicians, advance practice providers, nurses, respiratory therapists, and social workers who care for ILD patients at the 68 PFF Care Centers. Interstitial lung disease (ILD) causes a profound symptom burden and carries a high mortality. Palliative care is dedicated to improving quality of life and empowering patients in advance care planning. Early integration of Palliative Care in ILD improves the rates of advance care planning and symptomatic management. Knowledge of ILD provider perspectives on Palliative Care is key to improving care delivery to ILD patients. Descriptive statistics will be compiled for survey responses in the next fiscal year. The Survey for PFF Care Centers During the 2020 COVID-19 Pandemic was conducted by the PFF Care Center Network. The purpose of this survey is to gather center based information on the impact of the coronavirus disease (COVID-19) by developing functioning strategies for clinical trial networks in the event of the next surge or other event making physical visits not possible. The results from this survey will only be used for academic research in order to allow the PFF to move health initiatives and advocacy recommendations measures forward. Key research initiatives such as these we will make an impact in promoting earlier recognition and diagnosis of pulmonary fibrosis and ensuring that patients receive the highest quality healthcare. 4. Advocacy: During the year, the PFF engaged policymakers in advocating for increased funding for pulmonary fibrosis research and improved access to oxygen for patients. The PFF hosted a virtual Hill Day in March to allow constituents to speak with their members of Congress about the impact of pulmonary fibrosis in their lives and the need for research funding. The PFF successfully asked the Centers for Medicare and Medicaid Services to waive the in-person testing requirements for oxygen certification during the public health emergency caused by COVID-19. The PFF provided training to grassroots advocates on meeting with their lawmakers to advocate for the needs of the community. |
| 5. Research Grants | The Pulmonary Fibrosis Foundation (PFF) places enormous importance on creating an environment that will assist in the development of effective treatments for pulmonary fibrosis (PF). The PFF Scholars Program supports projects that offer a high likelihood of improving the understanding of PF in the following research areas: basic science, translational, clinical, epidemiological, and health services. The goal of the PFF Scholars Program is to support emerging investigators to advance research that could translate into successful therapies, while also enabling these promising researchers to obtain dependent funding and continue their cutting-edge research. The Research Review Committee administers the peer-reviewed process, which funds six $50,000 grants per cycle. The PFF also considers other smaller grants that fit the research guidelines. 6. Support Groups: The PFF Support Group Leader Network provides a forum for PF support group leaders to connect, exchange ideas, and share best practices. The PFFs Support Group Network consists of over 140 support groups across the country. During the public health emergency caused by COVID-19, many groups have been meeting virtually, with support from the PFF. Online Support Group communities are a great way for patients, caregivers, family members, and friends to virtually connect for support and information. For those who are unable to attend an in-person group, or simply want additional interactions between meetings, the Pulmonary Fibrosis Foundation offers two telephone-based support groups: PFF Voices and Caring Conversations. In addition, the PFF has added Coloquio, a Spanish-language telephone support group. These groups meet once per month over the phone in a conference call setting. Each monthly meeting provides a chance to discuss different topics related to pulmonary fibrosis, share personal stories, ask questions and provide support to one another. Visit http://bit.ly/pffsupport to learn more. 7. PFF Patient Communication Center (PCC): The PFF Patient Communication Center (PCC) serves as the central information hub for pulmonary fibrosis patients, caregivers, the Support Group Leader Network (see Support Group section), and health care professionals. The PCC staff provides general information about pulmonary fibrosis that is tailored to individuals needs and answers questions about the availability of support services and other essential resources. Resources available include: information on PFF programs, educational and advocacy materials, how to find medical care and support groups, access to support services, information about available treatments, and how to find clinical trials. The Foundation continuously surveys the PF community to determine additional educational materials or translations of current materials that are needed and works to develop those materials to fit unmet needs in the community. The Foundation also facilitates physician education by providing materials through the Patient Communication Center and at educational conferences. The Foundation maintains an Oxygen Information Line to provide patients and caregivers with general information on accessing and safely using supplemental oxygen. In fiscal year 2019-2020, the Patient Communication Center received 4,647 inquiries via telephone and email. |
| FORM 990, PART VI, SECTION B, LINE 11B: | A COPY OF FORM 990 IS REVIEWED BY THE FINANCE COMMITTEE BEFORE FILING. THE FORM 990 IS AVAILABLE TO ALL BOARD MEMBERS BEFORE FILING THE FORM. |
| FORM 990, PART VI, SECTION B, LINE 12C: | THE ORGANIZATION HAS A CONFLICT OF INTEREST POLICY WITHIN THE EMPLOYEE HANDBOOK AND ALL EMPLOYEES ARE REQUIRED TO ADHERE TO THE POLICY. EMPLOYEES SIGN A DISCLOSURE FORM EACH YEAR. ANNUALLY, BOARD MEMBERS ARE SENT A FORM TO FILL OUT STATING WHETHER THEY HAVE ANY CONFLICTS OF INTEREST. IF SUCH CONFLICTS EXIST, THEN THEY FILL OUT AN ADDITIONAL FORM OUTLINING THOSE CONFLICTS. THE EXECUTIVE COMMITTEE REVIEWS ANY CONFLICTS THAT ARISE. |
| FORM 990, PART VI, SECTION B, LINES 15A & B: | CHIEF EXECUTIVE OFFICER AND CHIEF OPERATING OFFICER'S COMPENSATION WAS APPROVED BY THE EXECUTIVE COMMITTEE, WHICH SERVES AS THE COMPENSATION COMMITTEE. THIS APPROVAL WAS BASED ON A REVIEW BY AN INDEPENDENT COMPENSATION CONSULTANT AND IS SUPPORTED BY A WRITTEN EMPLOYMENT CONTRACT. THE COMMITTEE ALSO REVIEWED COMPENSATION SURVEYS AND FORM 990S OF OTHER ORGANIZATIONS TO ENSURE THE COMPENSATION WAS APPROPRIATE. THE SALARY FOR THE CHIEF MARKETING OFFICER WAS NOT REVIEWED BY THE COMPENSATION COMMITTEE, BUT THE SALARY WAS IN LINE WITH THE MARKET. |
| FORM 990, PART VI, SECTION C, LINE 19: | THE ORGANIZATION MAKES ITS FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST AND ON THE ORGANIZATION'S WEBSITE. THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY AVAILABLE TO THE PUBLIC. |
| FORM 990 PART IX LINE 11G | DESCRIPTION:MARKETING CONSULTING TOTAL FEES:2290214 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:SITE PAYMENTS TOTAL FEES:894926 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:REGISTRY DCC CONSULTING TOTAL FEES:340612 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:OTHER CONSULTING TOTAL FEES:335191 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:MEDICAL CONSULTING TOTAL FEES:322143 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:REGISTRY CONSULTING TOTAL FEES:166965 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:CME TOTAL FEES:72250 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:RECRUITMENT FEES TOTAL FEES:54665 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:MERCHANT CARD CHARGES TOTAL FEES:48980 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:STIPENDS TOTAL FEES:22625 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:INVESTMENT FEES TOTAL FEES:21776 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:MEDIA RELATIONS TOTAL FEES:19685 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:COLLECTION KIT TOTAL FEES:19650 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:GRAPHIC DESIGN TOTAL FEES:19500 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:IT CONSULTING TOTAL FEES:15897 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:EMPLOYEE ADMINISTRATION FEES TOTAL FEES:13496 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:OTHER OUTSIDE SERVICES TOTAL FEES:13160 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:WRITING/EDITING TOTAL FEES:3660 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:PHOTOGRAPHY TOTAL FEES:2240 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:REGISTRY HRCT CONSULTING TOTAL FEES:-6989 |
Comments